Cargando…
Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide
INTRODUCTION: Riociguat, an oral soluble guanylate cyclase stimulator, has been approved for use in adults with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension. However, there is limited data on its therapeutic use in children. CASE PRESENTATION: We report the...
Autores principales: | Domingo, L. T., Ivy, D. D., Abman, S. H., Grenolds, A. M., MacLean, J. T., Breaux, J. A., Minford, K. J., Frank, B. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751701/ https://www.ncbi.nlm.nih.gov/pubmed/36533232 http://dx.doi.org/10.3389/fped.2022.1014922 |
Ejemplares similares
-
Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis
por: Patel, N. R., et al.
Publicado: (1999) -
Scurvy in a Pediatric Patient Unable to Bear Weight: A Case Report
por: Jafri, Aleena, et al.
Publicado: (2023) -
Cerebral hemodynamic response to a therapeutic bed for procedural pain management in preterm infants in the NICU: a randomized controlled trial
por: Ranger, Manon, et al.
Publicado: (2021) -
Calmer: a robot for managing acute pain effectively in preterm infants in the neonatal intensive care unit
por: Holsti, Liisa, et al.
Publicado: (2019) -
Association of Malnutrition With Weaning Practices Among Infants in Pakistan
por: Ajmal, Sidra, et al.
Publicado: (2022)